Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era-Reference-Cited by-同舟云学术

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

Published:2015-03-27 Issue:5 Volume:169 Page:683-688
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gunnarsson Niklas¹,Stenke Leif²³,Höglund Martin⁴,Sandin Fredrik⁵,Björkholm Magnus²³,Dreimane Arta⁶,Lambe Mats⁵⁷,Markevärn Berit⁸,Olsson-Strömberg Ulla⁴,Richter Johan⁹,Wadenvik Hans¹⁰,Wallvik Jonas¹,Själander Anders¹

Affiliation:

1. Department of Public Health and Clinical Medicine; Umeå University; Umeå Sweden

2. Department of Haematology; Karolinska University Hospital; Stockholm Sweden

3. Department of Medicine; Karolinska Institutet; Stockholm Sweden

4. Department of Medical Science and Division of Haematology; University Hospital; Uppsala Sweden

5. Regional Cancer Centre; Uppsala-Örebro Sweden

6. Department of Haematology; University Hospital; Linköping Sweden

7. Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden

8. Department of Haematology; University Hospital; Umeå Sweden

9. Department of Haematology and Vascular Disorders; Skåne University Hospital; Lund Sweden

10. Department of Haematology; Sahlgrenska University Hospital; Göteborg Sweden

Funder

Emil Andersson Research fund

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13346/fullpdf

Reference19 articles.

1. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;Baccarani;Blood,2013

2. The completeness of the Swedish Cancer Register: a sample survey for year 1998;Barlow;Acta Oncologica,2009

3. Secondary malignancies in CML patients - data from the German CML study IV;Barreto Miranda;Blood (ASH Annual Meeting Abstracts),2012

4. Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008;Björkholm;Journal of Clinical Oncology,2011

5. The pathogenesis and clinical patterns of blastic crisis of chronic myeloid leukemia;Boggs;Seminars in Oncology,1976

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nilotinib-induced alterations in endothelial cell function recapitulate clinical vascular phenotypes independent of ABL1;Scientific Reports;2024-03-26

2. A Rare Case of Dual Metachronous Primary Malignancies, Chronic Myeloid Leukemia, and Tongue Carcinoma in a Patient With Long-Standing Systemic Lupus Erythematosus: A Case Report and Review of Literature;Cureus;2024-03-21

3. Uncommon Haematological Transformation: Chronic Myeloid Leukaemia Transitioning Into Plasma Cell Leukaemia in a Single Patient;Cureus;2024-01-04

4. Secondary Ovarian Malignancy in an Imatinib treated Chronic Myeloid Leukemia Patient Diagnosed on Fluid Cytology;Clinical Cancer Investigation Journal;2023

5. Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia;Cancers;2022-09-26